510(k) K200467

Control-IQ Technology by Tandem Diabetes Care, Inc. — Product Code QJI

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 16, 2020
Date Received
February 26, 2020
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Interoperable Automated Glycemic Controller
Device Class
Class II
Regulation Number
862.1356
Review Panel
CH
Submission Type

An interoperable automated glycemic controller is a device intended to automatically calculate drug doses based on inputs such as glucose and other relevant physiological parameters, and to command the delivery of such drug doses from a connected infusion pump. Interoperable automated glycemic controllers are designed to reliably and securely communicate with digitally connected devices to allow drug delivery commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.